Suppr超能文献

[原发性小梁切除术治疗早发性先天性青光眼]

[Primary trabeculectomy for early-onset congenital glaucomas].

作者信息

Chiseliţă D, Bogdanici C, Hulubaş D, Muntian A, Vancea P P

机构信息

Clinica oftalmologică Iaşi.

出版信息

Oftalmologia. 1997;41(2):39-44.

Abstract

OBJECTIVE

Analysis of the results of primary trabeculectomy in the treatment of congenital glaucoma.

MATERIALS AND METHOD

Retrospective study of a series of 62 patients with primary trabeculectomy for congenital glaucoma, with a mean follow-up period of 2.22+/-2.86 years.

RESULTS

The last controlled intraocular pressure (IOP) was higher for the patients in the age group 0-1 year (16.9+/-8) as compared with the patients older than 1 year (14.9+/-7). An intraocular pressure < or = 20 mmHg without additional medication has been found in 58.3% of the cases in the 0-1 year age group, versus 65.8% in the group of patients older than 1 year. The number of reoperations was higher in the 0-1 year age group (14), as compared with the group of patients older than 1 year (8). The rate of qualified therapeutic success (IOP < or = 20 mmHg) was 79.1% in the 0-1 year age group, versus 85.5% in the group of patients older than 1 year.

CONCLUSIONS

Primary trabeculectomy is effective in the treatment of congenital glaucoma. The poorer results in the group of patients under 1 year of age is correlated with disease severity. The rate of favorable results is increased by reoperation, the majority of surgical failures belonging to the group of patients who needed reoperations.

摘要

目的

分析原发性小梁切除术治疗先天性青光眼的结果。

材料与方法

对62例行原发性小梁切除术治疗先天性青光眼的患者进行回顾性研究,平均随访时间为2.22±2.86年。

结果

0至1岁年龄组患者的末次眼压控制值(16.9±8)高于1岁以上患者(14.9±7)。0至1岁年龄组58.3%的病例眼压≤20 mmHg且无需额外用药,而1岁以上患者组这一比例为65.8%。0至1岁年龄组的再次手术例数(14例)高于1岁以上患者组(8例)。0至1岁年龄组的有效治疗成功率(眼压≤20 mmHg)为79.1%,而1岁以上患者组为85.5%。

结论

原发性小梁切除术治疗先天性青光眼有效。1岁以下患者组效果较差与疾病严重程度相关。再次手术可提高良好结果的比例,大多数手术失败病例属于需要再次手术的患者组。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验